Employer Health Savings Regenexx already partners with over 2,000 self-funded employer groups, offering a non-surgical, cost-saving alternative to orthopedic procedures. This indicates a large base of potential clients and a proven model for reducing claims costs, making them a strong target for expansion within existing employer networks and new self-funded plans.

Cost Reduction Opportunity With claims savings of up to 70 percent on orthopedic healthcare costs versus surgical options, there is a compelling value proposition for benefits managers seeking to optimize spend. Sales efforts can emphasize ROI timelines, clinical outcomes, and plan design enhancements tied to Regenexx benefits.

Clinical Differentiation Regenexx’s leadership in stem cell–based orthopedic treatments and high concentration processing (20x) positions it as a unique clinical offering. This can be leveraged to differentiate proposals, especially for plans targeting high orthopedic utilization or members seeking non-surgical care.

Partnership Network Licensing injectates and processes to a network of physicians creates a scalable distribution model. Business development can focus on expanding the physician network in underserved regions, streamlining enrollment with self-funded plans, and increasing utilization by employers with widespread geographic coverage.

Growth and Visibility With significant revenue and a clear growth trajectory, Regenexx benefits from marketing and case-study campaigns that highlight real-world savings and patient outcomes. Sales teams can leverage testimonials, utilization data, and employer case studies to drive interest among plan sponsors and HR leaders.